Oligonucleotides, short chains of nucleotides, are fundamental elements in various biological and biochemical applications, including gene therapy, diagnostics, and molecular biology research. To enhance their performance and adapt them to specific uses, oligonucleotides often undergo modifications. As an oligonucleotide supplier, I’m here to shed light on some of the common modifications that we offer and their significance in different fields. Oligonucleotide
1. Backbone Modifications
The backbone of an oligonucleotide is the phosphodiester linker that connects individual nucleotides. This structure is vulnerable to nuclease degradation in biological environments. By modifying the backbone, we can enhance the stability of oligonucleotides and improve their efficacy in vivo.
Phosphorothioate Modifications
One of the most widely used backbone modifications is the phosphorothioate (PS) modification. In a PS oligonucleotide, one of the non – bridging oxygen atoms in the phosphodiester bond is replaced by a sulfur atom. This simple substitution confers several advantages. Firstly, it significantly increases the resistance of oligonucleotides to nuclease degradation. In biological fluids such as blood and cell lysates, nucleases are abundant and can quickly break down unmodified oligonucleotides. The PS – modified oligonucleotides can persist longer, which is crucial for applications like antisense therapy where the oligonucleotides need to remain intact to bind to their target mRNA.
Secondly, PS modifications can enhance the binding affinity of oligonucleotides to certain proteins. This property is particularly useful in applications where the oligonucleotide needs to interact with specific cellular proteins. However, it’s important to note that a high degree of PS modification can also lead to non – specific binding and potential toxicity, so the degree of modification needs to be carefully optimized.
Morpholino Oligonucleotides
Morpholino oligonucleotides represent a unique type of backbone modification. Instead of the traditional ribose or deoxyribose sugar and phosphodiester backbone, morpholinos use a morpholine ring and a non – ionic phosphorodiamidate linkage. This results in several beneficial properties. Firstly, morpholinos are extremely resistant to nuclease degradation because the unique backbone structure is not recognized by nucleases.
Secondly, their non – ionic nature allows them to have a high degree of water solubility and reduces non – specific interactions with proteins and other cellular components. Morpholinos are commonly used in developmental biology research to knockdown gene expression by binding to the target mRNA and preventing its translation. Their high specificity and low toxicity make them an ideal choice for studying gene function in living organisms.
2. Sugar Modifications
The sugar moiety in oligonucleotides, either ribose or deoxyribose, can also be modified to enhance the properties of oligonucleotides. These modifications can affect the binding affinity, stability, and cellular uptake of oligonucleotides.
2′ – O – Methyl Modification
The 2′ – O – methyl (2′ – O – Me) modification involves the addition of a methyl group to the 2′ position of the ribose sugar. This modification enhances the nuclease resistance of oligonucleotides because the methyl group sterically hinders the access of nucleases to the phosphodiester bond.
In addition, 2′ – O – Me – modified oligonucleotides have a higher binding affinity to their target RNA compared to unmodified ones. This is due to the conformational change of the sugar moiety, which allows for better base – pairing with the target RNA. 2′ – O – Me – modified oligonucleotides are often used in RNA interference (RNAi) and antisense applications. They can be incorporated into small interfering RNAs (siRNAs) to increase their stability and efficacy in silencing specific genes.
Locked Nucleic Acids (LNAs)
Locked nucleic acids are a class of high – affinity RNA analogs. In LNAs, the ribose sugar is modified by the introduction of a methylene bridge that connects the 2′ oxygen and the 4′ carbon of the ribose ring, locking the sugar in a C3′ – endo conformation. This structural constraint has several important consequences.
Firstly, LNAs have an extremely high binding affinity to complementary RNA and DNA sequences. The locked conformation of the sugar allows for more efficient base – pairing, resulting in higher melting temperatures (Tm) of the duplex formed between the LNA – modified oligonucleotide and its target. Secondly, LNAs are highly resistant to nuclease degradation, which makes them suitable for in vivo applications. LNAs are widely used in diagnostic assays, such as fluorescence in situ hybridization (FISH), and in gene therapy to target and modulate the expression of disease – related genes.
3. Base Modifications
Base modifications can alter the properties of oligonucleotides in terms of base – pairing specificity, binding affinity, and fluorescent properties.
5 – Methylcytosine
5 – Methylcytosine is a naturally occurring base modification in DNA. It plays an important role in epigenetic regulation, such as gene silencing and chromosomal stability. In synthetic oligonucleotides, the incorporation of 5 – methylcytosine can mimic the natural epigenetic state and be used to study DNA – protein interactions related to epigenetic processes.
5 – Methylcytosine has similar base – pairing properties to cytosine, but the methyl group can affect the interaction with DNA – binding proteins. For example, some transcription factors recognize and bind to DNA sequences containing 5 – methylcytosine differently from unmethylated sequences. This property makes oligonucleotides containing 5 – methylcytosine valuable tools in epigenetic research.
Fluorescent Base Analogues
Fluorescent base analogues are modified bases that can emit fluorescence. They are commonly used in oligonucleotides for imaging and detection applications. For example, 2 – aminopurine is a fluorescent analogue of adenine. When incorporated into oligonucleotides, it can be used to monitor DNA or RNA hybridization events.
The fluorescence intensity of 2 – aminopurine changes depending on its environment, such as when it forms a base – pair with its complementary base. This allows researchers to monitor the real – time binding of oligonucleotides to their targets. Other fluorescent base analogues, such as dansyl – labeled nucleotides, can also be used to add fluorescent tags to oligonucleotides for various imaging and detection purposes.
4. Conjugation Modifications
Conjugation of oligonucleotides with other molecules can expand their functionality and improve their delivery to target cells.
Lipid Conjugation
Lipid conjugation is a common strategy to improve the cellular uptake of oligonucleotides. By attaching a lipid molecule, such as cholesterol or fatty acids, to the oligonucleotide, the hydrophobic nature of the lipid can facilitate the interaction of the oligonucleotide with the cell membrane.
Lipid – conjugated oligonucleotides can enter cells more efficiently through endocytosis or membrane fusion. This is particularly important for oligonucleotides used in gene therapy and antisense applications, as they need to reach the intracellular targets to be effective. In addition, lipid conjugation can also enhance the stability of oligonucleotides in biological fluids and reduce their renal clearance.
Peptide Conjugation
Peptide conjugation can endow oligonucleotides with unique properties. Cell – penetrating peptides (CPPs) are a class of peptides that can transport cargo molecules, including oligonucleotides, across the cell membrane. By conjugating oligonucleotides with CPPs, we can improve their intracellular delivery.
Some peptides can also target specific cell types or tissues. For example, peptides that can bind to receptors overexpressed on cancer cells can be conjugated to oligonucleotides for targeted cancer therapy. Peptide conjugation can also be used to modulate the biological activity of oligonucleotides, such as enhancing their binding to target molecules or altering their pharmacokinetic properties.
As an oligonucleotide supplier, we understand the diverse needs of our customers in different research and application fields. We offer a wide range of oligonucleotide modifications to meet your specific requirements. Whether you are conducting basic research in molecular biology or developing novel therapeutics, our high – quality modified oligonucleotides can provide reliable solutions.
API If you are interested in our products or have any questions about oligonucleotide modifications, please feel free to contact us for a detailed discussion. We are committed to providing the best services and products to support your research and development endeavors.
References
- Crooke, S. T. (2008). Progress in antisense oligonucleotide technology. Molecular Therapy, 16(1), 31 – 44.
- Kurreck, J. (2003). The structure of oligonucleotide duplexes containing locked nucleic acids. Nucleic Acids Research, 31(14), 4109 – 4118.
- Summerton, J. (1999). Morpholino antisense oligomers: design, preparation, and properties. Biochimica et Biophysica Acta (BBA) – Gene Structure and Expression, 1489(1), 141 – 158.
Zhejiang Hengkang Pharmaceutical Co., Ltd.
Zhejiang Hengkang Pharmaceutical Co., Ltd. is well-known as one of the leading oligonucleotide manufacturers and suppliers in China. With a professional production team, we are able to meet the needs of the majority of our customers. Please feel free to wholesale bulk high quality oligonucleotide from our factory.
Address: No.11 Chengen Road, Pubagang Town, Sanmen County, Zhejiang Province, China.
E-mail: commercial@hengkangpharm.cn
WebSite: https://www.hengkang-pharm.com/
